Bayesian Design of Superiority Trials: Methods and Applications

被引:2
|
作者
Yuan, Wenlin [1 ]
Chen, Ming-Hui [1 ]
Zhong, John [2 ]
机构
[1] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA
[2] REGENXBIO Inc, Rockville, MD USA
来源
STATISTICS IN BIOPHARMACEUTICAL RESEARCH | 2022年 / 14卷 / 04期
关键词
Borrowing-by-parts power prior; Conditional borrowing; Power prior; Sample size determination; SAMPLE-SIZE DETERMINATION; HISTORICAL CONTROL DATA; CLINICAL-TRIALS; SURVIVAL-DATA; MODEL; INFORMATION; DUCHENNE; PRIORS;
D O I
10.1080/19466315.2022.2090429
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this article, we lay out the basic elements of Bayesian sample size determination (SSD) for the Bayesian design of a two-arm superiority clinical trial. We develop a flowchart of the Bayesian SSD that highlights the critical components of a Bayesian design and provides a practically useful roadmap for designing a Bayesian clinical trial in real world applications. We empirically examine the amount of borrowing, the choice of noninformative priors, and the impact of model misspecification on the Bayesian Type I error and power. A formal and statistically rigorous formulation of conditional borrowing within the decision rule framework is developed. Moreover, by extending the partial borrowing power priors, a new borrowing-by-parts power prior for incorporating historical data is proposed. Computational algorithms are also developed to calculate the Bayesian Type I error and power. Extensive simulation studies are carried out to explore the operating characteristics of the proposed Bayesian design of a superiority trial.
引用
收藏
页码:433 / 443
页数:11
相关论文
共 50 条
  • [31] A Bayesian adaptive design for two-stage clinical trials with survival data
    Bandyopadhyay, Uttam
    Biswas, Atanu
    Bhattacharya, Rahul
    LIFETIME DATA ANALYSIS, 2009, 15 (04) : 468 - 492
  • [32] A Bayesian predictive two-stage design for phase II clinical trials
    Sambucini, Valeria
    STATISTICS IN MEDICINE, 2008, 27 (08) : 1199 - 1224
  • [33] A Bayesian adaptive design for two-stage clinical trials with survival data
    Uttam Bandyopadhyay
    Atanu Biswas
    Rahul Bhattacharya
    Lifetime Data Analysis, 2009, 15 : 468 - 492
  • [34] Bayesian Augmented Clinical Trials in TB Therapeutic Vaccination
    Kiagias, Dimitrios
    Russo, Giulia
    Sgroi, Giuseppe
    Pappalardo, Francesco
    Juarez, Miguel A.
    FRONTIERS IN MEDICAL TECHNOLOGY, 2021, 3
  • [35] Discussion of "Nonparametric Bayesian Inference in Applications": Bayesian nonparametric methods in econometrics
    Griffin, Jim
    Kalli, Maria
    Steel, Mark
    STATISTICAL METHODS AND APPLICATIONS, 2018, 27 (02) : 207 - 218
  • [36] A BAYESIAN METHOD FOR THE CHOICE OF THE SAMPLE SIZE IN EQUIVALENCE TRIALS
    Gubbiotti, Stefania
    De Santis, Fulvio
    AUSTRALIAN & NEW ZEALAND JOURNAL OF STATISTICS, 2011, 53 (04) : 443 - 460
  • [37] Bayesian hypothesis testing with frequentist characteristics in clinical trials
    Quan, Hui
    Zhang, Bingzhi
    Lan, Yu
    Luo, Xiaodong
    Chen, Xun
    CONTEMPORARY CLINICAL TRIALS, 2019, 87
  • [38] Bayesian design and analysis of active control clinical trials
    Simon, R
    BIOMETRICS, 1999, 55 (02) : 484 - 487
  • [39] A Bayesian adaptive design for clinical trials in rare diseases
    Williamson, S. Faye
    Jacko, Peter
    Villar, Sofia S.
    Jaki, Thomas
    COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2017, 113 : 136 - 153
  • [40] Applications of Bayesian analysis to proof-of-concept trial planning and decision making
    Quan, Hui
    Chen, Xun
    Lan, Yu
    Luo, Xiaodong
    Kubiak, Rene
    Bonnet, Nicolas
    Paux, Gautier
    PHARMACEUTICAL STATISTICS, 2020, 19 (04) : 468 - 481